Navigation Links
Amgen To Present At The Oppenheimer 24th Annual Healthcare Conference
Date:12/5/2013

THOUSAND OAKS, Calif., Dec. 5, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will participate at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, Dec. 10, 2013, at the Crowne Plaza in New York City, beginning at 9:45 a.m. Eastern Standard Time. Arvind Sood, vice president of Investor Relations at Amgen, will present at the conference. Live audio of the presentation can be accessed from the Events Calendar on Amgen's website, www.amgen.com, under Investors. A replay of the webcast will also be available on Amgen's website for 90 days following the event.

About Amgen
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. 

For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Ashleigh Koss, 805-313-6151 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: 

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Amgen To Webcast Investor Meeting At Upcoming American Heart Association Scientific Sessions 2013
2. Amgens Third Quarter 2013 Revenues Increased 10 Percent To $4.7 Billion And Adjusted Earnings Per Share (EPS) Increased 16 Percent To $1.94
3. Amgen Acquires Filgrastim Franchise Rights From Roche In 100 Markets
4. Amgen Successfully Completes Onyx Pharmaceuticals Tender Offer
5. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
6. Amgen And Cytokinetics Announce The First Presentation Of Data From Phase 2 ATOMIC-AHF Study Of Omecamtiv Mecarbil
7. Amgen To Participate At Citis 8th Annual Biotech Conference
8. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
9. Amgen to Highlight New Data at Upcoming ESC Congress 2013
10. Acquisition of Onyx Pharmaceuticals, Inc. by Amgen Inc. May Not Be in the Best Interests of Onyx Pharmaceuticals, Inc. Shareholders
11. Amgen To Acquire Onyx Pharmaceuticals For $125 Per Share In Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 24, 2014  Novastem, a leader ... first patient in its study for ischemic stroke ... Stroke Association, ischemic strokes account for 87 percent ... qualified patients in the study, entitled "Internal Research ... Allogeneic Mesenchymal Stem Cells and Intrathecal Administration of ...
(Date:12/24/2014)... PRINCETON, N.J. , Dec. 24, 2014 /PRNewswire/ ... Company), a late-stage biopharmaceutical company developing products that ... inflammation, oncology and biodefense, announced today that on ... registered public offering. The Company raised ... offering and intends to use the net proceeds ...
(Date:12/24/2014)... YORK and LONDON , ... global orthopedic industry are expected to grow at an ... in terms of value and volume. Hip, knee and ... developed world while in emerging economies they have a ... rates are challenging the use of composites. Non-metallic orthopedic ...
Breaking Medicine Technology:Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 2Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 3Novastem Treats First Patient Using Stemedica's Mesenchymal and Neural Stem Cell Combination Therapy for Ischemic Stroke 4Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3
... April 4, 2012  Syndicus, Inc. and Fayetteville, ... forged a strategic alliance that will ultimately ... paper-based records to federally mandated electronic health ... companies will work closely to promote and ...
... 4, 2012   CoreBrand , a leading brand strategy ... Branding Index® , which provides continuous benchmarking data, insights ... 54 industries, has recently been engaged by leading U.S. ... consumer industries for its expertise in crisis brand management. ...
Cached Medicine Technology:Syndicus, Inc. Scientific Services, SOAPware Announce Strategic Alliance 2Fortune 100 Companies Turning to CoreBrand for Its Expertise in Crisis Brand Management 2Fortune 100 Companies Turning to CoreBrand for Its Expertise in Crisis Brand Management 3
(Date:12/26/2014)... 2014 Cooking and warming equipment ... of 5. This score reflects slightly positive negotiation conditions ... specialization, low switching costs and a low level of ... low availability of substitutes for cooking and warming equipment ... and aluminum, key inputs in the production process of ...
(Date:12/26/2014)... 26, 2014 India Network Foundation, a ... the USA, announced today a new version of “ ... choosing the right plan for their visiting parents. The ... of the selection process when choosing an insurance plan ... with only a few clicks. Many elderly Asian Indian ...
(Date:12/25/2014)... This is a professional and in-depth study on ... a focus on the Chinese market. The report provides ... manufacturers and is a valuable source of guidance and ... This report provides a basic overview of the industry ... part, the report presents the company profile, product specifications, ...
(Date:12/25/2014)... months the trends for evening dresses shift and ... of the hottest styles in the next few months.” The ... 26 A-line sweetheart evening dresses, and announces the availability of ... trying our best to help a lady to show off ... prices, we provide discounted delivery costs to our customers worldwide. ...
(Date:12/25/2014)... BambooFlooringChina.com sells many bamboo products and the ... the company announces big discounts on its bamboo ... , BambooFlooringChina.com is the world’s leader in bamboo flooring. ... until Jan. 20, 2015. , The bamboo mats are ... natural thread. All the bamboo strips for the mats ...
Breaking Medicine News(10 mins):Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 2Health News:Cooking & Warming Equipment Procurement Category Market Research Report from IBISWorld has Been Updated 3Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 2Health News:India Network Health Insurance Announces new Comprehensive Pre-existing Condition Coverage policy for Visitors to the United States 3Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 2Health News:Sterilizers Industry Global and Chinese Analysis for 2009-2019 Now Available at ReportsnReports.com 3Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... (June 17, 2010)The Alliance for Academic Internal Medicine (AAIM) has ... education (GME) funding. In light of the current ... Commission,s (MedPAC,s) June 2010 report, AAIM encourages GME reform to ... The AAIM Principles for GME Reform ...
... ... medication expenses , ... Westerville, Ohio (PRWEB) June 17, 2010 -- Progressive Medical, Inc. ( http://www.progressive-medical.com ) announced ... medication spending on workers’ compensation claims from 2008 to 2009 for Progressive Medical clients, ...
... Normal weight and underweight teenage girls who falsely believe ... succumbing to unnecessary and unsafe weight-loss behaviors than girls ... new research by a University of Illinois expert in ... a professor of social work and of medicine at ...
... ... cost-effective cell culture media supplement that is consistent and animal component free. , ... Fort Collins, CO (PRWEB) ... steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators ...
... validated by others brings mental satisfaction, study finds , THURSDAY, ... often leads to a sense of satisfaction, and a new ... area of the brain is activated when people agree with ... used functional MRI scans to monitor activity in the ventral ...
... ... and a lot of potential solutions to water scarcity have steep energy costs. , ... (PRWEB) June 17, 2010 -- This ... energy is critical to treating and moving water. According to a new special report in ...
Cached Medicine News:Health News:Progressive Medical Releases 2010 Workers' Compensation Drug Spend Analysis 2Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 2Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 3Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 4Health News:Body-image distortion predicts onset of unsafe weight-loss behaviors 5Health News:Study Demonstrates a Safe and Cost Effective Source of Recombinant Human Transferrin 2Health News:Study Demonstrates a Safe and Cost Effective Source of Recombinant Human Transferrin 3Health News:Shared Opinions Light Up Brain's 'Reward Center' 2Health News:Green Energy May Drain Our Water Supplies 2Health News:Green Energy May Drain Our Water Supplies 3
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems....
Quatroloc Revision Hip System...
A stable revision design with extensive sizes...
Medicine Products: